A systematic review and meta-analysis of bacterial pathogen prevalence in acute and chronic rhinosinusitis: implications for empiric antibiotic therapy and antimicrobial stewardship.

Int J Infect DisMay 28, 2026 (epub)
Clinical ResearchOtolaryngology (ENT)

Hye Ok Kim, Suhyeon Ha, Jung Jae Shim et al.

✦ AI-curated · Sources linked

In 30 seconds

This systematic review and meta-analysis examined bacterial pathogen profiles in acute rhinosinusitis (ARS) and chronic rhinosinusitis (CRS) by analyzing 57 studies. The findings revealed that in ARS, methicillin-susceptible Staphylococcus aureus (MSSA) was the most prevalent pathogen at 20.5%, while in CRS, coagulase-negative staphylococci were most common at 24.3%.

Key findings

  • MSSA was the most prevalent pathogen in ARS at 20.5%.
  • Coagulase-negative staphylococci were most common in CRS at 24.3%.
  • S. pneumoniae was relatively infrequent in CRS at 9.4%.

Why it matters

Understanding the distinct bacterial profiles in ARS and CRS is crucial for guiding appropriate antibiotic therapy and improving antimicrobial stewardship. Tailoring treatment strategies based on these differences can enhance patient outcomes.

Source

Published in Int J Infect Dis. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Otolaryngology (ENT)

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.